White Paper

Understanding Immuno-Oncology Trials

Source: Chiltern

By Sharon Moore, MD, Chief Medical Officer, Chiltern

The immune system is a very finely tuned system and is designed to protect the body against attack from pathogens, including viruses, bacteria, and parasites, by targeting and destroying them. Its role also involves targeting and destroying cancer cells, and immuno-oncology therapeutics are designed to augment the immune response, helping the immune system to recognize the malignancy as foreign and therefore to attack it.

access the White Paper!

Get unlimited access to:

Trend and Thought Leadership Articles
Case Studies & White Papers
Extensive Product Database
Members-Only Premium Content
Welcome Back! Please Log In to Continue. X

Enter your credentials below to log in. Not yet a member of Clinical Leader? Subscribe today.

Subscribe to Clinical Leader X

Please enter your email address and create a password to access the full content, Or log in to your account to continue.

or

Subscribe to Clinical Leader